Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of propranolol on platelet function.

B B Weksler, M Gillick, J Pink

    Blood
    |February 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Propranolol reduces excessive platelet reactivity, a factor in atherosclerosis. This beta-blocker normalizes platelet aggregation and function, potentially protecting against vascular disease at typical doses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Surgical management of superficial digital flexor tendon luxation in dogs: 48 cases (2005-2020).

    The Journal of small animal practice·2021
    Same author

    Ventral acetabular augmentation for management of caudoventral luxation following total hip replacement in dogs.

    The Journal of small animal practice·2021
    Same author

    A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

    Current oncology (Toronto, Ont.)·2020
    Same author

    Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
    Same author

    International Forum regarding practices related to donor haemoglobin and iron.

    Vox sanguinis·2016
    Same author

    Re-evaluating the residual risk of transfusion-transmitted Ross River virus infection.

    Vox sanguinis·2016
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Area of Science:

    • Cardiovascular Pharmacology
    • Platelet Physiology

    Background:

    • Excessive blood platelet reactivity is linked to atherosclerotic vascular disease.
    • Drugs modulating platelet function may offer protective benefits.

    Purpose of the Study:

    • To investigate the in vitro effects of propranolol on platelet function.
    • To determine if propranolol's anti-platelet actions are related to beta-adrenergic blockade.

    Main Methods:

    • Assessed propranolol's effect on platelet aggregation induced by various agonists (ADP, epinephrine, collagen, thrombin, A23187).
    • Measured 14C-serotonin release, platelet adhesion to collagen, clot retraction, and 45Ca uptake.
    • Compared the effects of d(+) propranolol (inactive enantiomer) and practolol (non-lipophilic beta-blocker).

    Related Experiment Videos

    Main Results:

    • Propranolol raised aggregation thresholds for ADP-induced platelet aggregation at low concentrations (0.1-1 muM).
    • Higher propranolol concentrations (10-50 muM) inhibited aggregation, serotonin release, adhesion, and clot retraction.
    • Propranolol blocked calcium uptake, with effects independent of beta-adrenergic activity.

    Conclusions:

    • Propranolol directly modulates platelet responsiveness, likely via membrane action and interference with calcium availability.
    • These anti-platelet effects may contribute to propranolol's protective role in vascular disease.
    • Propranolol's influence on platelet function occurs at clinically relevant concentrations.